← Funding directory

Dated funding evidence

Owlstone Medical

Series E · $27M / £22M · 2025-01-15

Reported round$27M / £22MSeries E
Disclosure date
2025-01-15
Reported currency
USD
Companies House
04955647
Evidence sources
3

Company

Owlstone MedicalCH 04955647
2025-01-15Series E$27M / £22M

Resolved investor records

Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.

SourceVC research snapshot; Live Chris T D1Date2025-01-15Matchfunding_id joined to resolved canonical companyStatepublished

Record fields

What the source states

Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.

Round ID
FR-00484
Stage
Series E
Round name
Series E (first close)
Amount
$27M / £22M
Lead investors
Ventura Capital
Other investors
Aviva Ventures, Horizons Ventures, Gates Foundation
Source layers
VC research snapshot, Live Chris T D1
Snapshot
2026-08-15

Named evidence

Source trail

This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.

A 37X Ventures portfolio site

Operated by 37x Limited, a Guernsey Non Cellular Company, company number CMP76157, incorporated 18 July 2025.

Registered office: Les Echelons Court, Les Echelons, St. Peter Port, Guernsey, GY1 1AR.

Full company details